Global and China Prescription Dermatology Therapeutics Industry Market Research Report (2017-2028)

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the Prescription Dermatology Therapeutics industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • AbbVie

    • Amgen

    • Eli Lilly

    • Johnson & Johnson

    • Sun Pharmaceutical

    • Pfizer

    • Aclaris Therapeutics

    • Celgene

    • Bausch Health Companies

    • LEO Pharma

    • Novartis

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Fungal Infection Drugs

    • Skin Cancer Drugs

    • Acne & Rosacea Drugs

    • Psoriasis Drugs

    • Dermatitis & Seborrhea Drugs

    Application:

    • Hospital Pharmacies

    • Retail Pharmacies

    • Online Pharmacies

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Prescription Dermatology Therapeutics Industry Overview

      • 1.1.1 Prescription Dermatology Therapeutics Market Scope and Market Segments

      • 1.1.2 Prescription Dermatology Therapeutics Industry Characteristics

      • 1.1.3 Global and China Prescription Dermatology Therapeutics Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Prescription Dermatology Therapeutics Production Value and Growth Rate (2017-2028)

    • 1.2 Global Prescription Dermatology Therapeutics Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Fungal Infection Drugs

      • 1.2.2 Skin Cancer Drugs

      • 1.2.3 Acne & Rosacea Drugs

      • 1.2.4 Psoriasis Drugs

      • 1.2.5 Dermatitis & Seborrhea Drugs

    • 1.3 Global Prescription Dermatology Therapeutics Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospital Pharmacies

      • 1.3.2 Retail Pharmacies

      • 1.3.3 Online Pharmacies

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Prescription Dermatology Therapeutics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Prescription Dermatology Therapeutics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Prescription Dermatology Therapeutics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Prescription Dermatology Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Prescription Dermatology Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Prescription Dermatology Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Prescription Dermatology Therapeutics Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Prescription Dermatology Therapeutics Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Prescription Dermatology Therapeutics Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Prescription Dermatology Therapeutics Industry Porter's Five Forces Model Analysis

      • 2.2.3 Prescription Dermatology Therapeutics Industry PEST Analysis

    • 2.3 Prescription Dermatology Therapeutics Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Prescription Dermatology Therapeutics Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Prescription Dermatology Therapeutics Industry

    Chapter 3 Global and China Prescription Dermatology Therapeutics Market, by Manufacturer

    • 3.1 Global and China Prescription Dermatology Therapeutics Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Prescription Dermatology Therapeutics Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Prescription Dermatology Therapeutics Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Prescription Dermatology Therapeutics Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Prescription Dermatology Therapeutics Market Top 3 Players

    Chapter 4 Global and China Prescription Dermatology Therapeutics Market, by Type (2017-2028)

    • 4.1 Prescription Dermatology Therapeutics Market Trend, by Type

    • 4.2 Global Prescription Dermatology Therapeutics Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Prescription Dermatology Therapeutics Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Prescription Dermatology Therapeutics Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Prescription Dermatology Therapeutics Price Trend, by Type (2017-2028)

    • 4.3 China Prescription Dermatology Therapeutics Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Prescription Dermatology Therapeutics Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Prescription Dermatology Therapeutics Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Prescription Dermatology Therapeutics Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Prescription Dermatology Therapeutics Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Prescription Dermatology Therapeutics Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Prescription Dermatology Therapeutics Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Prescription Dermatology Therapeutics Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Prescription Dermatology Therapeutics Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Prescription Dermatology Therapeutics Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Prescription Dermatology Therapeutics Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Prescription Dermatology Therapeutics Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Prescription Dermatology Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Prescription Dermatology Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Prescription Dermatology Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Prescription Dermatology Therapeutics Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Prescription Dermatology Therapeutics Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Prescription Dermatology Therapeutics Market Analysis

    • 7.1 North America Prescription Dermatology Therapeutics Market, by Type

    • 7.2 North America Prescription Dermatology Therapeutics Market, by Application

    • 7.3 North America Prescription Dermatology Therapeutics Market Analysis and Forecast, by Country

      • 7.3.1 United States Prescription Dermatology Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Prescription Dermatology Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Prescription Dermatology Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Prescription Dermatology Therapeutics Market Analysis

    • 8.1 Europe Prescription Dermatology Therapeutics Market, by Type

    • 8.2 Europe Prescription Dermatology Therapeutics Market, by Application

    • 8.3 Europe Prescription Dermatology Therapeutics Market Analysis and Forecast, by Country

      • 8.3.1 Germany Prescription Dermatology Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Prescription Dermatology Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Prescription Dermatology Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Prescription Dermatology Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Prescription Dermatology Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Prescription Dermatology Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Prescription Dermatology Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Prescription Dermatology Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Prescription Dermatology Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Prescription Dermatology Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Prescription Dermatology Therapeutics Market Analysis

    • 9.1 APAC Prescription Dermatology Therapeutics Market, by Type

    • 9.2 APAC Prescription Dermatology Therapeutics Market, by Application

    • 9.3 APAC Prescription Dermatology Therapeutics Market Analysis and Forecast, by Country

      • 9.3.1 China Prescription Dermatology Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Prescription Dermatology Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Prescription Dermatology Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Prescription Dermatology Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Prescription Dermatology Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Prescription Dermatology Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Prescription Dermatology Therapeutics Market Analysis

    • 10.1 Latin America, Middle East and Africa Prescription Dermatology Therapeutics Market, by Type

    • 10.2 Latin America, Middle East and Africa Prescription Dermatology Therapeutics Market, by Application

    • 10.3 Latin America, Middle East and Africa Prescription Dermatology Therapeutics Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Prescription Dermatology Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Prescription Dermatology Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Prescription Dermatology Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Prescription Dermatology Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Prescription Dermatology Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Prescription Dermatology Therapeutics Company Profiles

      • 11.1 AbbVie

        • 11.1.1 AbbVie Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 AbbVie Prescription Dermatology Therapeutics Product Profiles, Application and Specification

        • 11.1.3 AbbVie Prescription Dermatology Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Amgen

        • 11.2.1 Amgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Amgen Prescription Dermatology Therapeutics Product Profiles, Application and Specification

        • 11.2.3 Amgen Prescription Dermatology Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Eli Lilly

        • 11.3.1 Eli Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Eli Lilly Prescription Dermatology Therapeutics Product Profiles, Application and Specification

        • 11.3.3 Eli Lilly Prescription Dermatology Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Johnson & Johnson

        • 11.4.1 Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Johnson & Johnson Prescription Dermatology Therapeutics Product Profiles, Application and Specification

        • 11.4.3 Johnson & Johnson Prescription Dermatology Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Sun Pharmaceutical

        • 11.5.1 Sun Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Sun Pharmaceutical Prescription Dermatology Therapeutics Product Profiles, Application and Specification

        • 11.5.3 Sun Pharmaceutical Prescription Dermatology Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Pfizer

        • 11.6.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Pfizer Prescription Dermatology Therapeutics Product Profiles, Application and Specification

        • 11.6.3 Pfizer Prescription Dermatology Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Aclaris Therapeutics

        • 11.7.1 Aclaris Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Aclaris Therapeutics Prescription Dermatology Therapeutics Product Profiles, Application and Specification

        • 11.7.3 Aclaris Therapeutics Prescription Dermatology Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Celgene

        • 11.8.1 Celgene Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Celgene Prescription Dermatology Therapeutics Product Profiles, Application and Specification

        • 11.8.3 Celgene Prescription Dermatology Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Bausch Health Companies

        • 11.9.1 Bausch Health Companies Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Bausch Health Companies Prescription Dermatology Therapeutics Product Profiles, Application and Specification

        • 11.9.3 Bausch Health Companies Prescription Dermatology Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 LEO Pharma

        • 11.10.1 LEO Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 LEO Pharma Prescription Dermatology Therapeutics Product Profiles, Application and Specification

        • 11.10.3 LEO Pharma Prescription Dermatology Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 Novartis

        • 11.11.1 Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 Novartis Prescription Dermatology Therapeutics Product Profiles, Application and Specification

        • 11.11.3 Novartis Prescription Dermatology Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Prescription Dermatology Therapeutics Industry Investment Prospect and Risk Assessment

    • 12.1 Prescription Dermatology Therapeutics Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Prescription Dermatology Therapeutics Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Prescription Dermatology Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure China Prescription Dermatology Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Global Prescription Dermatology Therapeutics Production Value and Growth Rate (2017-2028)

    • Figure China Prescription Dermatology Therapeutics Production Value and Growth Rate (2017-2028)

    • Figure Global Prescription Dermatology Therapeutics Market Size and Growth Rate of Fungal Infection Drugs (2017-2028)

    • Figure Global Prescription Dermatology Therapeutics Market Size and Growth Rate of Skin Cancer Drugs (2017-2028)

    • Figure Global Prescription Dermatology Therapeutics Market Size and Growth Rate of Acne & Rosacea Drugs (2017-2028)

    • Figure Global Prescription Dermatology Therapeutics Market Size and Growth Rate of Psoriasis Drugs (2017-2028)

    • Figure Global Prescription Dermatology Therapeutics Market Size and Growth Rate of Dermatitis & Seborrhea Drugs (2017-2028)

    • Figure Global Prescription Dermatology Therapeutics Market Size and Growth Rate of Hospital Pharmacies (2017-2028)

    • Figure Global Prescription Dermatology Therapeutics Market Size and Growth Rate of Retail Pharmacies (2017-2028)

    • Figure Global Prescription Dermatology Therapeutics Market Size and Growth Rate of Online Pharmacies (2017-2028)

    • Figure North America Prescription Dermatology Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Prescription Dermatology Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Prescription Dermatology Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Prescription Dermatology Therapeutics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Prescription Dermatology Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Prescription Dermatology Therapeutics Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Prescription Dermatology Therapeutics Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Prescription Dermatology Therapeutics Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Prescription Dermatology Therapeutics Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Prescription Dermatology Therapeutics Market Share, by Manufacturer in 2021

    • Figure Global and China Prescription Dermatology Therapeutics Market Share, by Manufacturer in 2022

    • Table Global Prescription Dermatology Therapeutics Sales Volume, by Type (2017-2028)

    • Table Global Prescription Dermatology Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure Global Prescription Dermatology Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table Global Prescription Dermatology Therapeutics Sales Value, by Type (2017-2028)

    • Table Global Prescription Dermatology Therapeutics Sales Value Share, by Type (2017-2028)

    • Figure Global Prescription Dermatology Therapeutics Price Trend, by Type (2017-2028)

    • Table China Prescription Dermatology Therapeutics Sales Volume, by Type (2017-2028)

    • Table China Prescription Dermatology Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure China Prescription Dermatology Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table China Prescription Dermatology Therapeutics Sales Value, by Type (2017-2028)

    • Table China Prescription Dermatology Therapeutics Sales Value Share, by Type (2017-2028)

    • Figure China Prescription Dermatology Therapeutics Price Trend, by Type (2017-2028)

    • Table Global Prescription Dermatology Therapeutics Sales Volume, by Application (2017-2028)

    • Table Global Prescription Dermatology Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Global Prescription Dermatology Therapeutics Sales Volume Share, by Application (2017-2028)

    • Table Global Prescription Dermatology Therapeutics Sales Value, by Application (2017-2028)

    • Table Global Prescription Dermatology Therapeutics Sales Value Share, by Application (2017-2028)

    • Figure Global Prescription Dermatology Therapeutics Sales Value Share, by Application (2017-2028)

    • Table China Prescription Dermatology Therapeutics Sales Volume, by Application (2017-2028)

    • Table China Prescription Dermatology Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure China Prescription Dermatology Therapeutics Sales Volume Share, by Application (2017-2028)

    • Table China Prescription Dermatology Therapeutics Sales Value, by Application (2017-2028)

    • Table China Prescription Dermatology Therapeutics Sales Value Share, by Application (2017-2028)

    • Figure China Prescription Dermatology Therapeutics Sales Value Share, by Application (2017-2028)

    • Figure China Prescription Dermatology Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure North America Prescription Dermatology Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Prescription Dermatology Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Prescription Dermatology Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Prescription Dermatology Therapeutics Production, Import, Consumption and Export (2017-2022)

    • Table North America Prescription Dermatology Therapeutics Sales Volume, by Type (2017-2028)

    • Table North America Prescription Dermatology Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure North America Prescription Dermatology Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table North America Prescription Dermatology Therapeutics Sales Volume, by Application (2017-2028)

    • Table North America Prescription Dermatology Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure North America Prescription Dermatology Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure United States Prescription Dermatology Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure United States Prescription Dermatology Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Canada Prescription Dermatology Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Prescription Dermatology Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Prescription Dermatology Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Prescription Dermatology Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table Europe Prescription Dermatology Therapeutics Sales Volume, by Type (2017-2028)

    • Table Europe Prescription Dermatology Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure Europe Prescription Dermatology Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table Europe Prescription Dermatology Therapeutics Sales Volume, by Application (2017-2028)

    • Table Europe Prescription Dermatology Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Europe Prescription Dermatology Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Germany Prescription Dermatology Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Prescription Dermatology Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure UK Prescription Dermatology Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure UK Prescription Dermatology Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure France Prescription Dermatology Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure France Prescription Dermatology Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Italy Prescription Dermatology Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Prescription Dermatology Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Prescription Dermatology Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Prescription Dermatology Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Spain Prescription Dermatology Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Prescription Dermatology Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Prescription Dermatology Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Prescription Dermatology Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Poland Prescription Dermatology Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Prescription Dermatology Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Russia Prescription Dermatology Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Prescription Dermatology Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Prescription Dermatology Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Prescription Dermatology Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table APAC Prescription Dermatology Therapeutics Sales Volume, by Type (2017-2028)

    • Table APAC Prescription Dermatology Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure APAC Prescription Dermatology Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table APAC Prescription Dermatology Therapeutics Sales Volume, by Application (2017-2028)

    • Table APAC Prescription Dermatology Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure APAC Prescription Dermatology Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure China Prescription Dermatology Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure China Prescription Dermatology Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Japan Prescription Dermatology Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Prescription Dermatology Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Prescription Dermatology Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Prescription Dermatology Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure India Prescription Dermatology Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure India Prescription Dermatology Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Prescription Dermatology Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Prescription Dermatology Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Prescription Dermatology Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Prescription Dermatology Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Prescription Dermatology Therapeutics Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Prescription Dermatology Therapeutics Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Prescription Dermatology Therapeutics Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Prescription Dermatology Therapeutics Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Prescription Dermatology Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Prescription Dermatology Therapeutics Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Prescription Dermatology Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Prescription Dermatology Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Prescription Dermatology Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Prescription Dermatology Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Prescription Dermatology Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Prescription Dermatology Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Prescription Dermatology Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Prescription Dermatology Therapeutics Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Prescription Dermatology Therapeutics Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Prescription Dermatology Therapeutics Sales Value and Growth Rate (2017-2028)

    • Table AbbVie Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table AbbVie Product Profiles, Application and Specification

    • Table AbbVie Prescription Dermatology Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Amgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Amgen Product Profiles, Application and Specification

    • Table Amgen Prescription Dermatology Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Eli Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Eli Lilly Product Profiles, Application and Specification

    • Table Eli Lilly Prescription Dermatology Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Johnson & Johnson Product Profiles, Application and Specification

    • Table Johnson & Johnson Prescription Dermatology Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sun Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sun Pharmaceutical Product Profiles, Application and Specification

    • Table Sun Pharmaceutical Prescription Dermatology Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pfizer Product Profiles, Application and Specification

    • Table Pfizer Prescription Dermatology Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Aclaris Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Aclaris Therapeutics Product Profiles, Application and Specification

    • Table Aclaris Therapeutics Prescription Dermatology Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Celgene Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Celgene Product Profiles, Application and Specification

    • Table Celgene Prescription Dermatology Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Bausch Health Companies Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bausch Health Companies Product Profiles, Application and Specification

    • Table Bausch Health Companies Prescription Dermatology Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table LEO Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table LEO Pharma Product Profiles, Application and Specification

    • Table LEO Pharma Prescription Dermatology Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novartis Product Profiles, Application and Specification

    • Table Novartis Prescription Dermatology Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.